JP7281016B2 - トリファロテンならびにその中間体および多形体の調製 - Google Patents

トリファロテンならびにその中間体および多形体の調製 Download PDF

Info

Publication number
JP7281016B2
JP7281016B2 JP2022534812A JP2022534812A JP7281016B2 JP 7281016 B2 JP7281016 B2 JP 7281016B2 JP 2022534812 A JP2022534812 A JP 2022534812A JP 2022534812 A JP2022534812 A JP 2022534812A JP 7281016 B2 JP7281016 B2 JP 7281016B2
Authority
JP
Japan
Prior art keywords
degrees
triphalotene
formula
polymorph
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2022534812A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022550632A (ja
Inventor
オザー，イラナ
カフタノフ，ユリア
シムホン，エリオット
ドゥシュキン，アンドレイ
シェファー・ディー－ヌール，シャニ
ピゼム，ヒレル
エイブラモフ，アヴィ
Original Assignee
タロー・ファーマシューティカル・インダストリーズ・リミテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by タロー・ファーマシューティカル・インダストリーズ・リミテッド filed Critical タロー・ファーマシューティカル・インダストリーズ・リミテッド
Publication of JP2022550632A publication Critical patent/JP2022550632A/ja
Priority to JP2023079468A priority Critical patent/JP2023100974A/ja
Application granted granted Critical
Publication of JP7281016B2 publication Critical patent/JP7281016B2/ja
Priority to JP2025188194A priority patent/JP2026016786A/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/155—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/06—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with radicals, containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/402—1-aryl substituted, e.g. piretanide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
JP2022534812A 2019-12-11 2020-12-10 トリファロテンならびにその中間体および多形体の調製 Active JP7281016B2 (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2023079468A JP2023100974A (ja) 2019-12-11 2023-05-12 トリファロテンならびにその中間体および多形体の調製
JP2025188194A JP2026016786A (ja) 2019-12-11 2025-11-07 トリファロテンならびにその中間体および多形体の調製

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962946943P 2019-12-11 2019-12-11
US62/946,943 2019-12-11
PCT/US2020/064365 WO2021119351A1 (en) 2019-12-11 2020-12-10 Preparation of trifarotene and intermediates and polymorphs thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023079468A Division JP2023100974A (ja) 2019-12-11 2023-05-12 トリファロテンならびにその中間体および多形体の調製

Publications (2)

Publication Number Publication Date
JP2022550632A JP2022550632A (ja) 2022-12-02
JP7281016B2 true JP7281016B2 (ja) 2023-05-24

Family

ID=74141909

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2022534812A Active JP7281016B2 (ja) 2019-12-11 2020-12-10 トリファロテンならびにその中間体および多形体の調製
JP2023079468A Pending JP2023100974A (ja) 2019-12-11 2023-05-12 トリファロテンならびにその中間体および多形体の調製
JP2025188194A Pending JP2026016786A (ja) 2019-12-11 2025-11-07 トリファロテンならびにその中間体および多形体の調製

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2023079468A Pending JP2023100974A (ja) 2019-12-11 2023-05-12 トリファロテンならびにその中間体および多形体の調製
JP2025188194A Pending JP2026016786A (ja) 2019-12-11 2025-11-07 トリファロテンならびにその中間体および多形体の調製

Country Status (9)

Country Link
US (2) US11691946B2 (https=)
EP (2) EP4073035B1 (https=)
JP (3) JP7281016B2 (https=)
CN (1) CN114787129B (https=)
AU (2) AU2020402049B2 (https=)
CA (1) CA3161509A1 (https=)
ES (1) ES3037292T3 (https=)
IL (2) IL293800B2 (https=)
WO (1) WO2021119351A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL293800B2 (en) * 2019-12-11 2024-10-01 Taro Pharma Ind Preparation of trifarotene and intermediates and polymorphs thereof
CN117342993A (zh) * 2022-07-05 2024-01-05 石家庄迪斯凯威医药科技有限公司 一种曲法罗汀盐及其药物组合物和用途
CN115745913B (zh) * 2022-09-16 2024-05-24 南京迈诺威医药科技有限公司 曲法罗汀多晶型及其制备方法
JP2026507122A (ja) * 2023-02-28 2026-02-27 タロー・ファーマシューティカル・インダストリーズ・リミテッド トリファロテンを調製する方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008525364A (ja) 2004-12-23 2008-07-17 ガルデルマ・リサーチ・アンド・デヴェロップメント Ｒａｒ受容体を調節する新規リガンド、並びにヒトの医薬品及び化粧品におけるその使用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1248869A2 (en) * 2000-01-07 2002-10-16 Transform Pharmaceuticals, Inc. High-throughput formation, identification, and analysis of diverse solid-forms
WO2004083335A2 (en) * 2003-03-21 2004-09-30 University Of Rochester Glassy chiral-nematic liquid crystals and optical devices containing same
US8354427B2 (en) 2004-06-24 2013-01-15 Vertex Pharmaceutical Incorporated Modulators of ATP-binding cassette transporters
DK1817301T3 (da) * 2004-11-22 2012-02-27 Lilly Co Eli Forstærkere af glutamat-receptorer
GB2426247A (en) 2005-05-20 2006-11-22 Arrow Int Ltd Methods of preparing purine derivatives such as famciclovir
EP3475312B1 (en) * 2016-06-23 2020-05-27 Galderma S.A. Cyclodextrin-grafted cross-linked hyaluronic acid complexed with active drug substances and uses thereof
IL293800B2 (en) * 2019-12-11 2024-10-01 Taro Pharma Ind Preparation of trifarotene and intermediates and polymorphs thereof

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008525364A (ja) 2004-12-23 2008-07-17 ガルデルマ・リサーチ・アンド・デヴェロップメント Ｒａｒ受容体を調節する新規リガンド、並びにヒトの医薬品及び化粧品におけるその使用

Also Published As

Publication number Publication date
JP2026016786A (ja) 2026-02-03
IL293800A (en) 2022-08-01
JP2022550632A (ja) 2022-12-02
EP4552691A3 (en) 2025-09-10
IL293800B1 (en) 2024-06-01
CA3161509A1 (en) 2021-06-17
WO2021119351A1 (en) 2021-06-17
US20230051259A1 (en) 2023-02-16
CN114787129B (zh) 2025-07-04
AU2023222982B2 (en) 2025-01-02
EP4073035B1 (en) 2025-05-07
NZ788464A (en) 2024-07-05
IL293800B2 (en) 2024-10-01
EP4073035A1 (en) 2022-10-19
US11691946B2 (en) 2023-07-04
IL312356A (en) 2024-06-01
JP2023100974A (ja) 2023-07-19
EP4552691A2 (en) 2025-05-14
AU2020402049B2 (en) 2023-06-01
CN114787129A (zh) 2022-07-22
AU2023222982A1 (en) 2023-09-21
US20230278956A1 (en) 2023-09-07
AU2020402049A1 (en) 2022-06-09
ES3037292T3 (en) 2025-09-30

Similar Documents

Publication Publication Date Title
JP7281016B2 (ja) トリファロテンならびにその中間体および多形体の調製
CN107108519B (zh) 制备ask1抑制剂的方法
CN103772297B (zh) 手性六元氮杂环卡宾前体化合物及其制备方法和应用
CN106496195A (zh) 巴瑞替尼及其中间体的新合成方法
JP5583009B2 (ja) 末端アルキンとアリールトシラートとをパラジウム触媒カップリングする方法
CN108779105A (zh) Buchwald-Hartwig芳基化方法用于制备叔芳族胺
CN109912661B (zh) 具有催化性能的嘧啶-吡唑金属钌配合物及其制备方法
JP2026507122A (ja) トリファロテンを調製する方法
HK40077817B (zh) 曲法罗汀及其中间体和多晶型物的制备
HK40077817A (zh) 曲法罗汀及其中间体和多晶型物的制备
CN109574778B (zh) 一种布瓦西坦及其中间体的制备方法
KR102456277B1 (ko) 방향족 아민의 모노아릴화
CN116332821A (zh) 一种5-(2-氟苯基)-1h-吡咯-3-甲腈的制备方法
CN104945434A (zh) (2﹣二取代膦苯基)-1-烷基-吲哚膦配体及其合成方法和应用
CN119977940B (zh) 一种氯虫苯甲酰胺杂质的制备方法
CN111285880A (zh) 一种含双冠醚的开关化合物的制备和应用
CN109071438B (zh) 用于制备非索非那定和其中使用的中间体的方法
CN106518832A (zh) 维帕他韦中间体9－溴－3－（2－溴乙酰基）－10，11－二氢－5H－二苯并［c，g］色烯－8（9h）－酮的制备方法
WO2025240628A1 (en) Processes for preparing a pkc inhibitor
WO2025140363A1 (zh) 一种苯基哌啶衍生物的制备方法
HK40066546B (zh) 一种三并环化合物的制备方法及其中间体
CN111153938A (zh) 手性单齿苯并咪唑-吲哚膦配体化合物及其制备方法和应用
CN106967046A (zh) 一种n‑杂芳基羟基咔唑类化合物的制备方法

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220708

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20220708

A871 Explanation of circumstances concerning accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A871

Effective date: 20220708

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20221226

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230324

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20230411

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230414

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20230425

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20230512

R150 Certificate of patent or registration of utility model

Ref document number: 7281016

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150